To reveal the significance of time-dependent drug properties in the interactions between IL-18 and chemotherapy, we tested the combinations of IL-18 with carboplatin or gemcitabine, two chemotherapeutic drugs that kill tumor cells in a dose-dependent manner. Here, IL18 is linked to neoplasm.